New Jersey · 2026-2027 Regular Session · Bill

S 301: Classifies 7 Hydroxymitragynine as Schedule I drug.

In committee Last action March 16, 2026: Referred to Senate Budget and Appropriations Committee

Plain-language summary

S 301 is a bill introduced in the New Jersey Senate on January 13, 2026. According to its official title, it concerns: Classifies 7 Hydroxymitragynine as Schedule I drug. Primary sponsor: Shirley Turner (Democratic), Kristin Corrado (Republican). It lists 2 additional sponsors. Most recent recorded action (March 16, 2026): Referred to Senate Budget and Appropriations Committee.

Sponsors

Primary sponsors: Shirley Turner (Democratic); Kristin Corrado (Republican). 2 co-sponsors.